CAMBRIDGE, MA
Allocation by class
Portfolio Concentration
Top 3 weight
84.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 21.45M
Full voting authority
21.45M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc.SOLE | Common Stock | 4.58M | SH | $381.30M 48.26% | 4.58M | 0.00 | 0.00 |
Dyne Therapeutics, Inc.SOLE | Common Stock | 9.13M | SH | $165.54M 20.95% | 9.13M | 0.00 | 0.00 |
Sionna Therapeutics, Inc.SOLE | Common Stock | 3M | SH | $120.09M 15.20% | 3M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | Common Stock | 1.51M | SH | $96.80M 12.25% | 1.51M | 0.00 | 0.00 |
Q32 Bio, Inc.SOLE | Common Stock | 2.09M | SH | $13.43M 1.70% | 2.09M | 0.00 | 0.00 |
Korro Bio, Inc.SOLE | Common Stock | 1.14M | SH | $12.87M 1.63% | 1.14M | 0.00 | 0.00 |